Europe Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Europe Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Europe gastric cancer diagnostics market is projected to register a CAGR of 8.1% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Europe Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest Of Europe) Industry Trends and Forecast To 2030

Some of the major factors contributing to the growth of the gastric cancer diagnostics market are:
• Rising healthcare expenditure for better health services
• Growing demand for better quality healthcare
• Increase in diagnostic procedures for gastric cancer

Market Players:

Some of the key market players in Europe gastric cancer diagnostics market are listed below:
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• Vela Diagnostics
• Abbott
• Fujirebio ( An H.U. Group company)
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• GENERAL ELECTRIC COMPANY
• Agilent Technologies, Inc.
• Biohit Oyj
• FOUNDATION MEDICINE, INC.
• DiaSorin S.p.A
• Paragon Genomics, Inc.
• QIAGEN

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Gastric Cancer Diagnostics Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Market End Coverage Grid
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Pestel's Model
4.2 Porter's 5 Forces
4.3 Epidemiology
4.4 Brand Analysis
4.5 Role Of Artificial Intelligence (Ai) And Machine Learning (Ml): Europe Gastric Cancer Diagnostics Market
4.6 Industry Insights:
5 Europe Gastric Cancer Diagnostics Market, Regulatory
5.1 European Union (Eu)-
6 Market Overview
6.1 Drivers
6.1.1 Increase In Incidence Of Gastrointestinal Tumours, Lymphoma, And Adenocarcinoma
6.1.2 Rise In Alcohol Consumption And Surge In Smoking
6.1.3 Increase In The Geriatric Population
6.1.4 Recent Advancements In Gastric Cancer Diagnostics Products
6.2 Restraints
6.2.1 High Cost Of Gastric Cancer Diagnostic Test
6.2.2 Lack Of Sufficient Financial Support From Health Insurance Policies
6.3 Opportunities
6.3.1 Rise In The Adoption Of Automated Systems
6.3.2 Increased Research And Development On Cancer Diagnostics Products
6.3.3 Strategic Initiatives By Emerging Players
6.4 Challenges
6.4.1 Stringent Regulations And Policies For Approving The Complicated Nature Of Radiation Devices
6.4.2 Limitations Of Radiation Tests
7 Europe Gastric Cancer Diagnostics Market, By Product Type
7.1 Overview
7.2 Reagents & Consumables
7.2.1 Kits
7.2.1.1 Dna Polymerase Kits
7.2.1.2 Pcr Kits
7.2.1.3 Nucleic Acid Isolation Kits
7.2.1.4 Others
7.2.2 Reagents
7.2.2.1 Assays
7.2.2.2 Buffers
7.2.2.3 Primers
7.2.2.4 Others
7.3 Instruments
7.4 Services
8 Europe Gastric Cancer Diagnostics Market, By Diagnostic Type
8.1 Overview
8.2 Confirmatory Test
8.2.1 Imaging Tests
8.2.1.1 Pet Scan/Ct Scan
8.2.1.2 Ct Scan
8.2.1.3 Ultrasound
8.2.1.4 Mri
8.2.1.5 X-ray
8.2.2 Biomarker
8.2.2.1 Dna Biomarker
8.2.2.2 Rna Biomarker
8.2.2.3 Protein Biomarker
8.2.3 Biopsy
8.3 Gastric Cancer Screening Tests/Physical Exam
9 Europe Gastric Cancer Diagnostics Market, By Age Group
9.1 Overview
9.2 Geriatrics
9.3 Adult
9.4 Pediatric
10 Europe Gastric Cancer Diagnostics Market, By Disease Type
10.1 Overview
10.2 Intestinal Or Diffuse Adenocarcinoma
10.3 Carcinoid Tumor
10.4 Gastrointestinal Stromal Tumor
10.5 Gastric Lymphoma
10.6 Others
11 Europe Gastric Cancer Diagnostics Market, By Stage
11.1 Overview
11.2 Stage I
11.2.1 Stage Ia
11.2.2 Stage Ib
11.3 Stage Ii
11.3.1 Stage Iia
11.3.2 Stage Iib
11.4 Stage Iii
11.4.1 Stage Iiia
11.4.2 Stage Iiib
11.4.3 Stage Iiic
11.5 Stage 0
12 Europe Gastric Cancer Diagnostics Market, By Gender
12.1 Overview
12.2 Male
12.3 Female
13 Europe Gastric Cancer Diagnostics Market, By Sample Type
13.1 Overview
13.2 Stool
13.3 Tissue
13.4 Blood
13.5 Urine
14 Europe Gastric Cancer Diagnostics Market, By End User
14.1 Overview
14.2 Hospitals
14.3 Diagnostic Laboratories
14.4 Cancer Research Institutes
14.5 Oncology Specialty Clinics
14.6 Others
15 Europe Gastric Cancer Diagnostics Market, By Distribution Channel
15.1 Overview
15.2 Direct Tenders
15.3 Retail Sales
16 Europe Gastric Cancer Diagnostics Market, By Region
16.1 Europe
16.1.1 Germany
16.1.2 France
16.1.3 U.K
16.1.4 Russia
16.1.5 Italy
16.1.6 Spain
16.1.7 Belgium
16.1.8 Netherlands
16.1.9 Turkey
16.1.10 Switzerland
16.1.11 Rest Of Europe
17 Europe Gastric Cancer Diagnostics Market, Company Landscape
17.1 Company Share Analysis: Europe
18 Swot Analysis
19 Company Profile
19.1 F. Hoffmann-la Roche Ltd
19.1.1 Company Snapshot
19.1.2 Revenue Analysis
19.1.3 Company Share Analysis
19.1.4 Product Portfolio
19.1.5 Recent Development
19.2 General Electric
19.2.1 Company Snapshot
19.2.2 Revenue Analysis
19.2.3 Company Share Analysis
19.2.4 Product Portfolio
19.2.5 Recent Development
19.3 Abbott
19.3.1 Company Snapshot
19.3.2 Revenue Analysis
19.3.3 Company Share Analysis
19.3.4 Product Portfolio
19.3.5 Recent Development
19.4 Qiagen
19.4.1 Company Snapshot
19.4.2 Revenue Analysis
19.4.3 Company Share Analysis
19.4.4 Product Portfolio
19.4.5 Recent Development
19.5 Myriad Genetics, Inc.
19.5.1 Company Snapshot
19.5.2 Revenue Analysis
19.5.3 Company Share Analysis
19.5.4 Product Portfolio
19.5.5 Recent Development
19.6 Acon Laboratories, Inc.
19.6.1 Company Snapshot
19.6.2 Product Portfolio
19.6.3 Recent Development
19.7 Advacare Pharma
19.7.1 Company Snapshot
19.7.2 Product Portfolio
19.7.3 Recent Development
19.8 Agilent Technologies, Inc.
19.8.1 Company Snapshot
19.8.2 Revenue Analysis
19.8.3 Product Portfolio
19.8.4 Recent Developments
19.9 Biomérieux
19.9.1 Company Snapshot
19.9.2 Revenue Analysis
19.9.3 Product Portfolio
19.9.4 Recent Development
19.10 Biocept, Inc.
19.10.1 Company Snapshot
19.10.2 Revenue Analysis
19.10.3 Product Portfolio
19.10.4 Recent Development
19.11 Biohit Oyj
19.11.1 Company Snapshot
19.11.2 Revenue Analysis
19.11.3 Product Portfolio
19.11.4 Recent Development
19.12 Diasorin S.P.A
19.12.1 Company Snapshot
19.12.2 Revenue Analysis
19.12.3 Product Portfolio
19.12.4 Recent Development
19.13 Endofotonics Pte Ltd
19.13.1 Company Snapshot
19.13.2 Product Portfolio
19.13.3 Recent Development
19.14 Foundation Medicine, Inc.
19.14.1 Company Snapshot
19.14.2 Product Portfolio
19.14.3 Recent Developments
19.15 Fujirebio (An H.U. Group Company)
19.15.1 Company Snapshot
19.15.2 Revenue Analysis
19.15.3 Product Portfolio
19.15.4 Recent Development
19.16 Mirxes Pte Ltd.
19.16.1 Company Snapshot
19.16.2 Product Portfolio
19.16.3 Recent Development
19.17 Paragon Genomics, Inc.
19.17.1 Company Snapshot
19.17.2 Product Portfolio
19.17.3 Recent Developments
19.18 Teco Diagnostics
19.18.1 Company Snapshot
19.18.2 Product Portfolio
19.18.3 Recent Development
19.19 Thermo Fisher Scientific Inc.
19.19.1 Company Snapshot
19.19.2 Revenue Analysis
19.19.3 Product Portfolio
19.19.4 Recent Developments
19.20 Vela Diagnostics
19.20.1 Company Snapshot
19.20.2 Product Portfolio
19.20.3 Recent Developments
20 Questionnaire
21 Related Reports 262
List Of Tables
Table 1 Approved Companion Diagnostic Device
Table 2 The Below-mentioned List Shows The Cost Of Pet Scan For Cancer Diagnosis In Different Regions Across The Globe-
Table 3 Europe Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 4 Europe Reagents & Consumables In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 5 Europe Reagent And Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 6 Europe Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 7 Europe Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 8 Europe Instruments In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 9 Europe Services In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 10 Europe Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 11 Europe Confirmatory Test In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 12 Europe Confirmatory Test In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 13 Europe Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 14 Europe Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 15 Europe Gastric Cancer Screening Tests/Physical Exam In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 16 Europe Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
Table 17 Europe Geriatrics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 18 Europe Adult In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 19 Europe Pediatric In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 20 Europe Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
Table 21 Europe Intestinal Or Diffuse Adenocarcinoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 22 Europe Carcinoid Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 23 Europe Gastrointestinal Stromal Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 24 Europe Gastric Lymphoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 25 Europe Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 26 Europe Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 27 Europe Stage I In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 28 Europe Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 29 Europe Stage Ii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 30 Europe Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 31 Europe Stage Iii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 32 Europe Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 33 Europe Stage 0 In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 34 Europe Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
Table 35 Europe Male In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 36 Europe Female In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 37 Europe Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
Table 38 Europe Stool In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 39 Europe Tissue In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 40 Europe Blood In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 41 Europe Urine In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 42 Europe Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 43 Europe Hospitals In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 44 Europe Diagnostic Laboratories In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 45 Europe Cancer Research Institutes In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 46 Europe Oncology Specialty Clinics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 47 Europe Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 48 Europe Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 49 Europe Direct Tenders In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 50 Europe Retail Sales In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 51 Europe Surgical Power Tools Market, By Country, 2021-2030 (Usd Million)
Table 52 Europe Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 53 Europe Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 54 Europe Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 55 Europe Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 56 Europe Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 57 Europe Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 58 Europe Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 59 Europe Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 60 Europe Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
Table 61 Europe Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
Table 62 Europe Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 63 Europe Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 64 Europe Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 65 Europe Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 66 Europe Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
Table 67 Europe Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
Table 68 Europe Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 69 Europe Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 70 Germany Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 71 Germany Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 72 Germany Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 73 Germany Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 74 Germany Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 75 Germany Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 76 Germany Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 77 Germany Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 78 Germany Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
Table 79 Germany Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
Table 80 Germany Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 81 Germany Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 82 Germany Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 83 Germany Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 84 Germany Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
Table 85 Germany Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
Table 86 Germany Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 87 Germany Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 88 France Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 89 France Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 90 France Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 91 France Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 92 France Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 93 France Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 94 France Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 95 France Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 96 France Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
Table 97 France Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
Table 98 France Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 99 France Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 100 France Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 101 France Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 102 France Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
Table 103 France Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
Table 104 France Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 105 France Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 106 U.K. Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 107 U.K. Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 108 U.K. Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 109 U.K. Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 110 U.K. Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 111 U.K. Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 112 U.K. Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 113 U.K. Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 114 U.K. Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
Table 115 U.K. Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
Table 116 U.K. Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 117 U.K. Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 118 U.K. Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 119 U.K. Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 120 U.K. Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
Table 121 U.K. Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
Table 122 U.K. Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 123 U.K. Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 124 Russia Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 125 Russia Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 126 Russia Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 127 Russia Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 128 Russia Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 129 Russia Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 130 Russia Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 131 Russia Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 132 Russia Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
Table 133 Russia Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
Table 134 Russia Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 135 Russia Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 136 Russia Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 137 Russia Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
Table 138 Russia Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
Table 139 Russia Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
Table 140 Russia Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 141 Russia Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 142 Italy Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 143 Italy Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 144 Italy Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 145 Italy Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 146 Italy Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 147 Italy Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 148 Italy Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
Table 149 Italy Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Europe Gastric Cancer Diagnostics Market: Segmentation
Figure 2 Europe Gastric Cancer Diagnostics Market: Data Triangulation
Figure 3 Europe Gastric Cancer Diagnostics Market: Droc Analysis
Figure 4 Europe Gastric Cancer Diagnostics Market: Europe Vs. Regional Market Analysis
Figure 5 Europe Gastric Cancer Diagnostics Market: Company Research Analysis
Figure 6 Europe Gastric Cancer Diagnostics Market: Multivariate Modelling
Figure 7 Europe Gastric Cancer Diagnostics Market: Interview Demographics
Figure 8 Europe Gastric Cancer Diagnostics Market: Dbmr Market Position Grid
Figure 9 Europe Gastric Cancer Diagnostics Market: Vendor Share Analysis
Figure 10 Europe Gastric Cancer Diagnostics Market: Market End Coverage Grid
Figure 11 Europe Gastric Cancer Diagnostics Market: Segmentation
Figure 12 Increase In The Incidence Of Gastrointestinal Tumors, Lymphoma, And Adenocarcinoma Is Expected To Drive The Europe Gastric Cancer Diagnostics Market Growth In The Forecast Period Of 2023 To 2030
Figure 13 Reagents And Consumables Segment Is Expected To Account For The Largest Share Of The Europe Gastric Cancer Diagnostics Market In 2023 & 2030
Figure 14 Drivers, Restraints, Opportunities, And Challenges, Of The Europe Gastric Cancer Diagnostics Market
Figure 15 Europe Gastric Cancer Diagnostics Market: By Product Type, 2022
Figure 16 Europe Gastric Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
Figure 17 Europe Gastric Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
Figure 18 Europe Gastric Cancer Diagnostics Market: By Product Type, Lifeline Curve
Figure 19 Europe Gastric Cancer Diagnostics Market: By Diagnostic Type, 2022
Figure 20 Europe Gastric Cancer Diagnostics Market: By Diagnostic Type, 2023-2030 (Usd Million)
Figure 21 Europe Gastric Cancer Diagnostics Market: By Diagnostic Type, Cagr (2023-2030)
Figure 22 Europe Gastric Cancer Diagnostics Market: By Diagnostic Type, Lifeline Curve
Figure 23 Europe Gastric Cancer Diagnostics Market: By Age Group, 2022
Figure 24 Europe Gastric Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
Figure 25 Europe Gastric Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
Figure 26 Europe Gastric Cancer Diagnostics Market: By Age Group, Lifeline Curve
Figure 27 Europe Gastric Cancer Diagnostics Market: By Disease Type, 2022
Figure 28 Europe Gastric Cancer Diagnostics Market: By Disease Type, 2023-2030 (Usd Million)
Figure 29 Europe Gastric Cancer Diagnostics Market: By Disease Type, Cagr (2023-2030)
Figure 30 Europe Gastric Cancer Diagnostics Market: By Disease Type, Lifeline Curve
Figure 31 Europe Gastric Cancer Diagnostics Market: By Stage, 2022
Figure 32 Europe Gastric Cancer Diagnostics Market: By Stage, 2023-2030 (Usd Million)
Figure 33 Europe Gastric Cancer Diagnostics Market: By Stage, Cagr (2023-2030)
Figure 34 Europe Gastric Cancer Diagnostics Market: By Stage, Lifeline Curve
Figure 35 Europe Gastric Cancer Diagnostics Market: By Gender, 2022
Figure 36 Europe Gastric Cancer Diagnostics Market: By Gender, 2023-2030 (Usd Million)
Figure 37 Europe Gastric Cancer Diagnostics Market: By Gender, Cagr (2023-2030)
Figure 38 Europe Gastric Cancer Diagnostics Market: By Gender, Lifeline Curve
Figure 39 Europe Gastric Cancer Diagnostics Market: By Sample Type, 2022
Figure 40 Europe Gastric Cancer Diagnostics Market: By Sample Type, 2023-2030 (Usd Million)
Figure 41 Europe Gastric Cancer Diagnostics Market: By Sample Type, Cagr (2023-2030)
Figure 42 Europe Gastric Cancer Diagnostics Market: By Sample Type, Lifeline Curve
Figure 43 Europe Gastric Cancer Diagnostics Market: By End User, 2022
Figure 44 Europe Gastric Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
Figure 45 Europe Gastric Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Figure 46 Europe Gastric Cancer Diagnostics Market: By End User, Lifeline Curve
Figure 47 Europe Gastric Cancer Diagnostics Market: By Distribution Channel, 2022
Figure 48 Europe Gastric Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 49 Europe Gastric Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
Figure 50 Europe Gastric Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
Figure 51 Europe Gastric Cancer Diagnostics Market: Snapshot (2022)
Figure 52 Europe Gastric Cancer Diagnostics Market: By Country (2022)
Figure 53 Europe Gastric Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 54 Europe

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings